Physician
Rainbow Pediatrics PC LLC
Rainbow Pediatrics PC LLC was paid $8.34M by Medicaid between Feb 2018 and Dec 2024, across 73 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 47% of everything it billed.
33Billing provider infoRAINBOW PEDIATRICS PC LLC
PANAMA CITY, FL 32405
PANAMA CITY, FL 32405
33aNPI1134569049assigned 06/25/2013
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$8.34M
24GClaims227,260
24DCodes billed73
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Florida
Rank by total paid#1 of 56
Median peer was paid$221K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 53 | $1K | |
| 2019 | 33,480 | $974K | |
| 2020 | 30,611 | $923K | |
| 2021 | 42,933 | $1.38M | |
| 2022 | 52,025 | $1.86M | |
| 2023 | 46,971 | $2.10M | |
| 2024incomplete | 21,187 | $1.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 47% | 66,433 | 53,930 | $3.94M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 9,270 | 7,948 | $900K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 8,992 | 8,396 | $881K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.8% | 6,889 | 6,423 | $737K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.6% | 3,579 | 3,417 | $381K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.0% | 14,671 | 13,675 | $250K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 6,505 | 5,913 | $180K |
| 99460 | 2.0% | 2,105 | 1,892 | $166K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 8,731 | 7,961 | $159K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 16,122 | 14,726 | $145K |
| 94060 | 1.3% | 2,936 | 2,667 | $106K | |
| 90461 | 1.1% | 6,533 | 6,065 | $94K |
61 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.0% | 704 | $85K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,747 | $52K |
| 99462 | <1% | 2,652 | $48K | |
| 99223 | Prolong inpt eval add15 m | <1% | 167 | $39K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 11,030 | $32K |
| 99188 | <1% | 2,052 | $20K | |
| 87807 | <1% | 2,669 | $19K | |
| 92552 | <1% | 5,380 | $19K | |
| 92558 | <1% | 2,137 | $16K | |
| 99051 | <1% | 1,877 | $9K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,242 | $8K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 287 | $8K |
| 90686 | <1% | 2,284 | $7K | |
| H0049 | Alcohol and/or drug screening | <1% | 737 | $6K |
| 90670 | <1% | 4,126 | $6K | |
| 99381 | <1% | 76 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 260 | $4K |
| 69210 | <1% | 124 | $3K | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 2,229 | $3K |
| 31000 | <1% | 109 | $3K | |
| 81002 | <1% | 1,508 | $3K | |
| 88720 | <1% | 1,345 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 285 | $1K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 21 | $1K |
| 90744 | <1% | 2,509 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 22 | $638.27 |
| 92587 | <1% | 49 | $565.76 | |
| 90698 | <1% | 3,199 | $439.94 | |
| 90677 | <1% | 426 | $410.00 | |
| 97803 | <1% | 110 | $397.46 | |
| 83655 | <1% | 715 | $390.16 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 337 | $328.81 |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 43 | $303.25 |
| 85018 | <1% | 902 | $219.41 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 222 | $213.84 |
| 99050 | <1% | 134 | $207.02 | |
| 81025 | <1% | 30 | $181.02 | |
| 90710 | <1% | 1,418 | $157.67 | |
| 90633 | <1% | 1,644 | $154.73 | |
| 90700 | <1% | 567 | $153.28 | |
| 99177 | <1% | 8,362 | $118.15 | |
| 90648 | <1% | 445 | $110.96 | |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | <1% | 1,521 | $104.43 |
| 90680 | <1% | 2,504 | $64.82 | |
| 90696 | <1% | 269 | $40.50 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 17 | $40.03 |
| 36416 | <1% | 1,246 | $37.65 | |
| 90685 | <1% | 46 | $31.50 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 17 | $23.46 |
| 90715 | <1% | 90 | $22.00 | |
| 94664 | <1% | 63 | $11.43 | |
| 90651 | 0% | 188 | $0.00 | |
| 90723 | 0% | 21 | $0.00 | |
| 90716 | 0% | 33 | $0.00 | |
| 94760 | 0% | 67 | $0.00 | |
| 99239 | Hospital discharge day management, more than 30 minutes | 0% | 12 | $0.00 |
| H0033 | Oral medication administration, direct observation | 0% | 14 | $0.00 |
| 90707 | 0% | 34 | $0.00 | |
| 90621 | 0% | 44 | $0.00 | |
| 90734 | 0% | 113 | $0.00 | |
| 99173 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREZK, AHMED (OWNER)